Skip to main content

Year: 2020

Century Global Commodities Corporation Completes Acquisition of Joint Venture Interests of WISCO Canada ADI Resources Development & Investment Limited in Century’s Attikamagen and Sunny Lake Projects

TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) has completed its previously announced acquisition from WISCO Canada ADI Resources Development & Investment Limited (“WISCO ADI”), a 23.5% shareholder of Century, of WISCO ADI’s joint venture interests in Century’s Attikamagen and Sunny Lake iron ore projects (the “Joint Venture Interests”) in exchange for net cash consideration of $1.17 million (the “Acquisition”). The Acquisition was completed through the facilities of the Shanghai United Assets and Equity Exchanges (the “Shanghai United Exchange”).As a result of the completion of the Acquisition, Century’s joint venture agreements with WISCO ADI for Century’s Attikamagen and Sunny Lake iron ore projects have been terminated and Century is now the owner of a 100%...

Continue reading

Trident Acquisitions Corp. Announces Binding Letter of Intent to Combine with Lottery.com

– Business Combination to Bring Public a Leading Online Platform to Play the Lottery –– Lottery.com Grew Revenue at a CAGR of 279% from 2016-2019; Significant Industry Tailwinds Poised to Further Accelerate Growth –NEW YORK and AUSTIN, Texas, Nov. 19, 2020 (GLOBE NEWSWIRE) — Trident Acquisitions Corp. (NASDAQ: TDACU, TDAC, TDACW) (“Trident”), announced that it has entered into a binding letter of intent (“LOI”) for a business combination transaction with Lottery.com, which would result in Lottery.com (the “Company”) becoming a publicly traded company on The Nasdaq Stock Market.Founded in 2015, Lottery.com is a leading online platform to play the lottery from your phone, offering official state-sanctioned lottery games, like Powerball, Mega-Millions and state games, in the U.S. and around the world....

Continue reading

Kapitalforeningen BankInvest Select – Prospekt

København Ø, Nov. 19, 2020 (GLOBE NEWSWIRE) —Opdateret prospekt for Kapitalforeningen BankInvest Select offentliggøres dags dato.Der er foretaget en generel opdatering af risiko-afsnit, herunder risikoeksponeringer.Endvidere er prospektet opdateret med finanskalender, sproglige præciseringer og korrekturrettelser.Dokumentet kan downloades fra www.bankinvest.dk eller rekvireres ved henvendelse til BI Management A/S, Sundkrogsgade 7, 2100 København Ø, tlf. 77 30 90 00.Med venlig hilsenBI Management A/SMartin Fjordlund SmidtDirektørVedhæftede filerProspekt Kap. BankInvest Select 2020.11.19 cleanVedtægter Kap BankInvest Select 2020.09.07 Clean

Continue reading

XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail

AUSTIN, Texas, Nov. 19, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) announced today new data for its breakthrough candidate therapy for treating infections of influenza and COVID-19. The Company continues to analyze components of its so-called FLUVID™ therapy as it develops manufacturing capability for a product candidate. The True Human antibodies targeting the virus causing COVID-19 were found to effectively neutralize a test virus at concentrations about four-times better than the antibodies the FDA is now considering for emergency use authorization. Ongoing research has also found that the True Human antibodies in this therapeutic cocktail that target influenza are capable of rescuing 100% of animals that receive an otherwise lethal dose of flu virus. The latest research findings suggest the FLUVID™ therapy, designed...

Continue reading

RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones

ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) — RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the issuance of two new patents encompassing improvements to the SkinGun™, expanding its potential application beyond the surgical setting into the field, and allowing the use of liquid suspension solutions to include drugs, hormones, and other useful agents. These new patents demonstrate RenovaCare’s commitment to developing new products and expanding its proprietary cell spray technology platforms.Robin A. Robinson, PhD, Chief Scientific Officer commented, “RenovaCare is leading the development of regenerative medical spray cell therapies with our novel CellMist™ System and SkinGun™...

Continue reading

Eyewear Market to Reach USD 178.95 Billion with 5.7% CAGR by 2026; Witness Progressive Growth Rate Attributable to Surge in Geriatric Population and Prevalence of Eye Diseases, Predicts Fortune Business Insights™

Pune, India, Nov. 19, 2020 (GLOBE NEWSWIRE) — The eyewear market size is predicted to be worth USD 178.95 billion by the end of 2026 from USD 115.90 billion in 2018. The forecast period is set from 2019 to 2026 and the market is expected to exhibit a CAGR of 5.7%. With respect to product type, the market will be dominated by the spectacles segment owing to the rising prevalence of eye disorders such as hypermetropia and myopia. In 2018, North America generated an eyewear market revenue of USD 35.60 billion and dominated the market. This domination is attributable to factors such as a rise in awareness about ocular disorders, and preference for premium eye care products.The global eyewear market size is anticipated to expand owing to the increasing awareness about ocular diseases, coupled with the rise in prevalence of vision abnormality....

Continue reading

Investeringsforeningen BankInvest – Prospekt

København Ø, Nov. 19, 2020 (GLOBE NEWSWIRE) —Opdateret prospekt for Investeringsforeningen BankInvest offentliggøres dags dato.Der er foretaget en generel opdatering af risiko-afsnit, herunder risikoeksponeringer.Endvidere er prospektet opdateret med finanskalender, sproglige præciseringer og korrekturrettelser.Dokumentet kan downloades fra www.bankinvest.dk eller rekvireres ved henvendelse til BI Management A/S, Sundkrogsgade 7, 2100 København Ø, tlf. 77 30 90 00.Med venlig hilsenBI Management A/SMartin Fjordlund SmidtDirektørVedhæftede filerProspekt Inv. BankInvest – 2020.11.19 cleanVedtægter Inv. BankInvest 2020.08.04 inkl. tillæg A Godkendt af FT 2020.09.04

Continue reading

Investeringsforeningen BankInvest – Finanskalender 2021

København Ø, Nov. 19, 2020 (GLOBE NEWSWIRE) —For så vidt angår finanskalenderen for 2021 for Investeringsforeningen BankInvest er denne fastsat således:Årsrapport for 2020: den 18. marts 2021Ordinær generalforsamling: den 22. april 2021Halvårsrapport 1. halvår 2021: den 26. august 2021Med venlig hilsenBI Management A/SMartin Fjordlund SmidtDirektør

Continue reading

Hamilton Thorne Reports Financial and Operational Results for the Quarter and Nine Months Ended September 30, 2020

BEVERLY, Mass. and TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited financial and operational results for the quarter and nine months ended September 30, 2020.HighlightsSales increased 10% year over year to $9.8 million for the quarter; sales for the nine-month period increased 12% to $27.5 million; constant currency increase of 8% for the quarter and 13% for the nine-month periodGross profit increased 3% year over year to $4.9 million for the quarter; increased 8% to $12.9 million for the nine-month periodNet income increased 41% to $459 thousand for the quarter; net income of $10 thousand for the nine-month period...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.